Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04072445
What this trial is testing

Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Gallbladder CarcinomaRefractory Bile Duct Carcinoma+15 more
Mayo Clinic 28
Large-scale testing (Phase 3)Not Yet RecruitingNCT06571461
What this trial is testing

Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
CSPC Ouyi Pharmaceutical Co., Ltd. 408
Large-scale testing (Phase 3)Active Not RecruitingNCT03829462
What this trial is testing

Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Institut du Cancer de Montpellier - Val d'Aurelle 377
Testing effectiveness (Phase 2)Study completedNCT00156286
What this trial is testing

Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC

Who this might be right for
Small Cell Lung Cancer
University of Michigan Rogel Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00308529
What this trial is testing

Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer

Who this might be right for
Carcinoma, Small Cell LungLung Cancer
SCRI Development Innovations, LLC 55
Early research (Phase 1)Not Yet RecruitingNCT06491134
What this trial is testing

Liposomal Irinotecan With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital 12
Testing effectiveness (Phase 2)UnknownNCT04833036
What this trial is testing

C-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRI

Who this might be right for
Colorectal Cancer
Fudan University 120
Post-approval studies (Phase 4)Study completedNCT00140036
What this trial is testing

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

Who this might be right for
Colorectal Neoplasms
Pfizer 137
Testing effectiveness (Phase 2)Study completedNCT00022698
What this trial is testing

Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 67
Early research (Phase 1)Study completedNCT00003463
What this trial is testing

Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Testing effectiveness (Phase 2)UnknownNCT06467565
What this trial is testing

NALIRIFOX as Induction Therapy in LAPC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06816771
What this trial is testing

Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents

Who this might be right for
Rhabdomyosarcoma, Recurrent, Refractory
Shandong Cancer Hospital and Institute 38
Testing effectiveness (Phase 2)Ended earlyNCT03879798
What this trial is testing

DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00230399
What this trial is testing

Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Michigan Rogel Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT00258232
What this trial is testing

Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07521605
What this trial is testing

Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer

Who this might be right for
Rectal Cancer Patients
Guangdong Provincial People's Hospital 44
Early research (Phase 1)UnknownNCT06225622
What this trial is testing

Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Shanghai Zhongshan Hospital 78
Testing effectiveness (Phase 2)Study completedNCT00020930
What this trial is testing

Cetuximab in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00597402
What this trial is testing

Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas

Who this might be right for
GlioblastomaGliosarcomaBrain Tumor
Duke University 125
Testing effectiveness (Phase 2)Ended earlyNCT01004159
What this trial is testing

Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan

Who this might be right for
Colorectal Cancer
Roswell Park Cancer Institute 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation